Penobscot Investment Management Company, Inc.
Position in AZN — Astrazeneca PLC
CIK 1394866
BOSTON, MA
Position in AZN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$11,410,193
+$1,532,824 QoQ
Shares Held
60,174
+20.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#293
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Penobscot Investment Management Company, Inc. holds $78,402,280 across 11 Drug Manufacturers - General names. AZN ranks #4 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
77,452 | $19,490,021 | |
| 2 | LLY |
ELI LILLY & Co
|
12,634 | $15,153,599 | |
| 3 | JNJ |
Johnson & Johnson
|
55,938 | $14,206,573 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
60,174 | $11,410,193 | |
| 5 | AMGN |
Amgen Inc
|
16,503 | $5,976,066 | |
| 6 | NVS |
Novartis AG
|
26,577 | $4,165,147 | |
| 7 | MRK |
Merck & Co., Inc.
|
31,382 | $4,032,587 | |
| 8 | PFE |
Pfizer Inc
|
79,410 | $1,912,192 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,410,193 | 60,174 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $9,877,369 | 50,083 | Shares | Sole | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||